Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Liquid Tank Exploded at Kitasato Daiichi Sankyo Vaccine, No Pathogens Escaped
February 27, 2018
- 1st–in-Human Trial Begins for ADC DS-1062 in NSCLC: Daiichi Sankyo
February 26, 2018
- Mitsubishi Tanabe to Complete PIII for Plant-Derived Flu Vaccine in April, Obtain Top-Line Data around Summer
February 26, 2018
- Nomura Picked as Next Chief of Sumitomo Dainippon, Vows to Build Peripheral Healthcare Biz
February 26, 2018
- Sid Singh Named as New President of GSK Consumer Healthcare Japan
February 26, 2018
- Diagnogreen Applied for Evaluation of Blood Flow: Daiichi Sankyo
February 23, 2018
- Fujifilm to Set Up New Manufacturing Facility for Liposome Drugs, Operation Launch Targeted in Feb. 2020
February 23, 2018
- Pfizer Japan No Longer Disclosing Biosimilar Development Status for “Competitive Reasons”
February 23, 2018
- Sumitomo Dainippon’s iPSC-Based Parkinson’s Therapy Set for IIT Launch in FY2018
February 22, 2018
- Nippon Kayaku’s Novel Paclitaxel Form in Breast Cancer PII after PIII Miss
February 22, 2018
- Takeda, Wave Ink Antisense Pact for Neurological Diseases
February 22, 2018
- Novartis Japan Chief on Rare Paternity Leave, Looks to Lead by Example
February 22, 2018
- Bristol-Myers Japan Taps Ex-AZ Exec Hashigami as Development Chief
February 21, 2018
- Taniuchi Appointed as Santen President and COO
February 21, 2018
- Aducanumab Trial Tweak “Common Decision” to Boost Statistical Confidence: Biogen CEO
February 21, 2018
- Seikagaku to Run Add’l PIII for Lumbar Disc Herniation Drug in US
February 20, 2018
- Fujifilm Starts Japan PII for Radiopharmaceutical in Pheochromocytoma
February 20, 2018
- Dovobet Gel Wins Japan Approval: LEO/Kyowa Kirin
February 20, 2018
- Medical System Network Taps into Generic Business via Its Dispensing Pharmacy Chains, Aiming at Future Expansion
February 20, 2018
- Takeda’s Specialty Biz Unit Most Likely to Handle GI Meds, Entyvio Launch Apparently Eyed
February 20, 2018
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…